Completed PHASE4 INTERVENTIONAL 2-arm NCT00607035

The Japan-Combined Treatment With Olmesartan and a Calcium Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study (J-CORE)

Sponsor: Jichi Medical University

Interventions Olmesartan medoxomil + Hydrochlorothiazide Olmesartan medoxomil ＋Azelnidipine

Updated 5 times since 2017 Last updated: Nov 19, 2008 Started: May 31, 2006 Primary completion: Apr 30, 2008 Completion: May 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Hypertension and is currently completed. Jichi Medical University leads this study, which shows 5 recorded versions since 2006 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

May 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jichi Medical University

Data source: Jichi Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tochigi, Japan